[{"id":"55c35159-1ba7-4b9a-9cf4-f8da0e3f2f67","acronym":"","url":"https://clinicaltrials.gov/study/NCT03941457","created_at":"2022-03-01T23:52:34.080Z","updated_at":"2024-07-02T16:36:59.829Z","phase":"Phase 1/2","brief_title":"Clinical Research of ROBO1 Specific BiCAR-NK Cells on Patients With Pancreatic Cancer","source_id_and_acronym":"NCT03941457","lead_sponsor":"Asclepius Technology Company Group (Suzhou) Co., Ltd.","biomarkers":" ROBO1","pipe":"","alterations":" ","tags":["ROBO1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ROBO1 CAR-NK cells"],"overall_status":"Unknown status","enrollment":" Enrollment 9","initiation":"Initiation: 05/01/2019","start_date":" 05/01/2019","primary_txt":" Primary completion: 05/01/2021","primary_completion_date":" 05/01/2021","study_txt":" Completion: 05/01/2022","study_completion_date":" 05/01/2022","last_update_posted":"2019-05-08"},{"id":"d71a1e23-cbc4-4d19-8573-c2e7b390aabd","acronym":"","url":"https://clinicaltrials.gov/study/NCT03940820","created_at":"2022-03-01T23:52:33.811Z","updated_at":"2024-07-02T16:36:59.844Z","phase":"Phase 1/2","brief_title":"Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors","source_id_and_acronym":"NCT03940820","lead_sponsor":"Asclepius Technology Company Group (Suzhou) Co., Ltd.","biomarkers":" ROBO1","pipe":"","alterations":" ","tags":["ROBO1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ROBO1 CAR-NK cells"],"overall_status":"Unknown status","enrollment":" Enrollment 20","initiation":"Initiation: 05/01/2019","start_date":" 05/01/2019","primary_txt":" Primary completion: 05/01/2021","primary_completion_date":" 05/01/2021","study_txt":" Completion: 05/01/2022","study_completion_date":" 05/01/2022","last_update_posted":"2019-05-07"},{"id":"762820a2-189d-4299-945d-ff67decefd35","acronym":"","url":"https://clinicaltrials.gov/study/NCT03931720","created_at":"2022-03-01T23:52:33.446Z","updated_at":"2024-07-02T16:37:00.057Z","phase":"Phase 1/2","brief_title":"Clinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor","source_id_and_acronym":"NCT03931720","lead_sponsor":"Asclepius Technology Company Group (Suzhou) Co., Ltd.","biomarkers":" ROBO1","pipe":"","alterations":" ","tags":["ROBO1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ROBO1 CAR-NK cells"],"overall_status":"Unknown status","enrollment":" Enrollment 20","initiation":"Initiation: 05/01/2019","start_date":" 05/01/2019","primary_txt":" Primary completion: 05/01/2021","primary_completion_date":" 05/01/2021","study_txt":" Completion: 05/01/2022","study_completion_date":" 05/01/2022","last_update_posted":"2019-04-30"}]